Olympus America

Press Center

Olympus Announces New, Enhanced PK7200 Thresholds for Conventional ABO Reagent Red Blood Cells

Orlando - (American Association of Blood Banks Annual Meeting) Oct. 26, 2002.

Enhancing its line of timesaving solutions, Olympus Diagnostic Systems Group today announced improved flexibility for plasma ABO testing on the Olympus PK7200 analyzers.

Olympus has validated a new set of thresholds for use with the conventional Reagent Red Blood Cells (RBC) used for ABO plasma testing. Conventional RBC are sourced from donor EDTA samples, donor units or from commercial RBC used for manual testing. The new thresholds provide result interpretation rates similar to the rates obtained with the original parameters, but now additional threshold limits improve the ability of the instrument to detect error conditions, such as dispensing errors.

The new thresholds also complement the Olympus PK Reagent Red Blood Cells. These reagents differ from conventional RBC in that they are manufactured specifically for the PK7200 to ensure lot-to-lot consistency and require no user preparation. They are packaged in 55 mL vials rather than the10 mL vials used for manual commercial RBC. The new thresholds for conventional RBC are identical to the thresholds approved for use with the Olympus PK RBC. By allowing the same set of thresholds to be used for both types of RBC reagents, during routine operation the operator can easily switch between these reagents without the need to reprogram the PK7200 and perform validation.

The FDA with both conventional RBC as well as the Olympus PK RBC has cleared the new thresholds for use. These new thresholds will make the PK7200 and the Olympus PK RBC reagents easier to use and will improve process control when testing with conventional RBC. Complementary ABO antisera have already been cleared by the FDA for use on the PK7200. The availability of Rh antisera pre-qualified for use on the PK7200 instrument is anticipated by early 2003, subject to FDA clearance.

For additional information, please contact Candace Williams, Director/Immunohematology Systems, Olympus Diagnostic Systems Group, at (800) 628-7152, ext. 2681. Fax: (972) 432-9532. Email: Candace.Williams@olympus.com

About Olympus Diagnostic Systems Group
Since 1981, Olympus Diagnostic Systems Group has provided innovative solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks and pharmaceutical labs. Offering the broadest standardized line of random access, chemistry-immuno analyzers and lab automation systems, Olympus' solutions save laboratories time, maximize productivity and deliver fast, reliable results.

Olympus Diagnostic Systems Group also offers rapid response technical support nationwide through Olympus Technical Services. Service and support are available to customers seven days a week, 24 hours a day, by calling 1-800-223-0130. From telephone troubleshooting and remote modem diagnostics…on-site customer training and service for hardware, software, application support…as well as training and field support at Olympus' Irving, Texas facility…Olympus Diagnostic Systems Group provides comprehensive customer-tailored solutions to ensure maximum system uptime with reliable results.

For additional information about the Olympus product line, and other services, please call the Olympus Diagnostic Systems Group at (800) 223-0125, or visit the Olympus web site at www.olympusamerica.com.

About Olympus
Olympus Optical Co., Ltd., with its wholly owned subsidiaries, is a global leader in designing, manufacturing and marketing optical-digital product solutions for health care and consumer segments. The company leverages R&D investment in technology and manufacturing processes across diverse business lines that include:

  • minimally invasive diagnostic and surgical endoscopes;
  • advanced clinical and research microscopes;
  • chemistry-immuno analyzers and lab automation systems; and
  • digital and film cameras, and digital voice recorders.
  • In the U. S. and Canada, Olympus America Inc. serves health care, scientific and commercial laboratory markets with integrated product solutions and financial and other service offerings and is the leading brand in gastrointestinal endoscopy and clinical and educational microscopes. The company's market-leading consumer camera products and services business spans North and South America. Olympus America Inc. works collaboratively with its customers and parent company to develop state-of-the-art products and services that are innovative, intelligent, and easy to use. For more information, visit www.olympusamerica.com.